CJC-1295 with DAC is a long-acting GHRH-style peptide. GHRH stands for growth hormone-releasing hormone: the signal that tells the pituitary gland to release growth hormone. The DAC part helps extend the signal, which is why this version is treated differently from shorter CJC or Sermorelin-style peptides.

CJC-1295 with DAC 5mg vial.

People look at CJC-1295 with DAC because growth-hormone signalling is connected with sleep quality, recovery, body composition, exercise adaptation, IGF-1 output, and age-related changes in hormone rhythm. The DAC version is usually chosen for comparison when people want to understand longer-acting growth-hormone signalling rather than shorter pulse-style signalling.

CJC-1295 mimics the body’s GHRH signal to the pituitary. The pituitary responds by releasing growth hormone, which then connects downstream with IGF-1 and repair-and-metabolism signalling. DAC helps the peptide bind to albumin, extending its activity window compared with non-DAC versions.

CJC-1295 is often compared with Sermorelin, Ipamorelin, and NuPulse-style blends. Sermorelin is another GHRH-style peptide, Ipamorelin works through ghrelin receptors, and NuPulse uses CJC-1295 without DAC alongside Ipamorelin.

Growth-hormone secretagogues and GHRH analogues may be restricted or prohibited in sport and other regulated settings.

This information is educational only. It is not medical advice, dosing guidance, usage instruction, or a recommendation. Discussion and interest should not be read as guaranteed outcomes or instructions to combine products.